2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

@article{Jennette20132012RI,
  title={2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.},
  author={J. Jennette and R. Falk and P. Bacon and N. Basu and M. Cid and F. Ferrario and L. Flores-Su{\'a}rez and W. Gross and L. Guillevin and E. Hagen and G. Hoffman and D. Jayne and C. Kallenberg and P. Lamprecht and C. Langford and R. Luqmani and A. Mahr and E. Matteson and P. Merkel and S. Ozen and C. Pusey and N. Rasmussen and A. Rees and D. Scott and U. Specks and J. Stone and K. Takahashi and R. Watts},
  journal={Arthritis and rheumatism},
  year={2013},
  volume={65 1},
  pages={
          1-11
        }
}
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides J. Jennette;R. Falk;P. Bacon;N. Basu;M. Cid;F. Ferrario;L. Flores-Suarez;W. Gross;L. Guillevin;E. Hagen;G. Hoffman;D. Jayne;C. Kallenberg;P. Lamprecht;C. Langford;R. Luqmani;A. Mahr;E. Matteson;P. Merkel;S. Ozen;C. Pusey;N. Rasmussen;A. Rees;D. Scott;U. Specks;J. Stone;K. Takahashi;R. Watts; Arthritis & Rheumatism 

Paper Mentions

Observational Clinical Trial
VASCO is a prospective observational cohort study which aim to describe the presentation, comorbidities, management, outcomes and damage of vasculitis patients, from the analysis of… Expand
ConditionsVasculitis
InterventionOther
Interventional Clinical Trial
Previous reports suggested conventional immunosuppressants such as cyclophosphamide could not reduce glucocorticoid dose in remission induction in ANCA-associated vasculitis because of… Expand
ConditionsAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis, Wegener Granulomatosis
InterventionDrug
Interventional Clinical Trial
Overall design: Single-center, randomized, blinded, placebo-controlled single- and multiple-ascending dose study in healthy adult subjects.  
ConditionsSafety Issues
InterventionBiological, Drug
[Vasculitis: New nomenclature of the Chapel Hill consensus conference 2012].
[Systemic vasculitides: some debatable aspects of the problem].
Evolving concepts in classification of systemic vasculitis: where are we and what is the way forward?
  • R. Watts
  • Medicine
  • International journal of rheumatic diseases
  • 2019
Classification of ANCA-Associated Vasculitis
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 23 REFERENCES
Granulomatosis with polyangiitis (Wegener's): An alternative name for Wegener's granulomatosis
Renal involvement in Churg-Strauss syndrome.
  • E. Clutterbuck, D. Evans, C. Pusey
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 1990
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.
Hypocomplementemic urticarial vasculitis syndrome: an interdisciplinary challenge.
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.
ANCA-associated vasculitides—advances in pathogenesis and treatment
Crescentic glomerulonephritis: new aspects of pathogenesis.
...
1
2
3
...